| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $14K | — | -63.2% |
| Cost of Revenue | $42K | — | +5.0% |
| R&D Expense | $3.0M | — | -9.1% |
| SG&A Expense | $4.3M | — | -3.5% |
| Operating Income | -$9.4M | — | -1.2% |
| Interest Expense | $2K | — | -50.0% |
| Net Income | -$8.4M | — | -2.6% |
| EPS (Basic) | -$0.17 | — | +15.0% |
| EPS (Diluted) | -$0.17 | — | +15.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $4.2M | +5.9% | -20.2% |
| Short-term Investments | $43.2M | +22.6% | +5.5% |
| Accounts Receivable | $11K | -8.3% | -56.0% |
| Current Assets | $49.7M | +22.0% | +5.2% |
| Total Assets | $93.5M | -8.2% | -20.8% |
| Current Liabilities | $23.4M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$8.8M | — | -16.2% |
| Capital Expenditures | $8K | — | +166.7% |
| Investing Cash Flow | $9.0M | — | +120.1% |
| Financing Cash Flow | $20K | — | -100.0% |
| Free Cash Flow | -$8.8M | — | -16.2% |
| +0.1% |
| Total Liabilities | $25.9M | -2.3% | +10.8% |
| Stockholders' Equity | $67.6M | -10.3% | -28.7% |